Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xandra García-González, Sara López-Tarruella, María Isabel García, Eva González-Haba, Carolina Blanco, Sara Salvador-Martin, Yolanda Jerez, Fabienne Thomas, María Jarama, María Sanjurjo Sáez, Miguel Martín & Luis Andrés López-Fernández. (2018) Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene. Cancer Management and Research 10, pages 4517-4522.
Read now
Read now
Marta Pellicer, Xandra García-González, María I García, Carolina Blanco, Pilar García-Alfonso, Luis Robles, Cristina Grávalos, Daniel Rueda, Joaquín Martínez, Vanessa Pachón, Federico Longo, Virginia Martínez, Irene Iglesias, Sara Salvador, María Sanjurjo & Luis A López-Fernández. (2017) Use of Exome Sequencing to Determine the Full Profile of Genetic Variants in the Fluoropyrimidine Pathway in Colorectal Cancer Patients Affected by Severe Toxicity. Pharmacogenomics 18:13, pages 1215-1223.
Read now
Read now
Articles from other publishers (5)
Nada Božina, Ivan Bilić, Lana Ganoci, Livija Šimičević, Stjepko Pleština, Lucija Lešnjaković & Vladimir Trkulja. (2021)
DPYD
polymorphisms
c.496A>G
,
c.2194G>A
and
c.85T>C
and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols
. British Journal of Clinical Pharmacology 88:5, pages 2190-2202.
Crossref
Crossref
Seid Hamzic, Dominic Schärer, Steven M. Offer, Didier Meulendijks, Christos Nakas, Robert B. Diasio, Stefano Fontana, Marc Wehrli, Stefan Schürch, Ursula Amstutz & Carlo R. Largiadèr. (2021)
Haplotype structure defines effects of common
DPYD
variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5‐fluorouracil toxicity
. British Journal of Clinical Pharmacology 87:8, pages 3234-3243.
Crossref
Crossref
Yasmin Cura, Cristina Pérez Ramírez, Almudena Sánchez Martín, Fernando Martínez Martínez, Miguel Ángel Calleja Hernández, María del Carmen Ramírez Tortosa & Alberto Jiménez Morales. (2021) Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives. Mutation Research/Reviews in Mutation Research 788, pages 108391.
Crossref
Crossref
Valeria Conti, Emanuela De Bellis, Valentina Manzo, Francesco Sabbatino, Francesco Iannello, Fabrizio Dal Piaz, Viviana Izzo, Bruno Charlier, Berenice Stefanelli, Martina Torsiello, Teresa Iannaccone, Albino Coglianese, Francesca Colucci, Stefano Pepe & Amelia Filippelli. (2020) A Genotyping/Phenotyping Approach with Careful Clinical Monitoring to Manage the Fluoropyrimidines-Based Therapy: Clinical Cases and Systematic Review of the Literature. Journal of Personalized Medicine 10:3, pages 113.
Crossref
Crossref
Francis Lévi, Abdoulaye Karaboué, Raphaël Saffroy, Christophe Desterke, Valerie Boige, Denis Smith, Mohamed Hebbar, Pasquale Innominato, Julien Taieb, Carlos Carvalho, Rosine Guimbaud, Christian Focan, Mohamed Bouchahda, René Adam, Michel Ducreux, Gérard Milano & Antoinette Lemoine. (2017) Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). British Journal of Cancer 117:7, pages 965-973.
Crossref
Crossref